Dosage mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy20

K562 Cells Philadelphia Chromosome Cell Line, Tumor X Chromosome Chromosomes, Human, Pair 9 Cells, Cultured Neoplastic Stem Cells Sex Chromosomes Myeloid Progenitor Cells Orbit Bone Marrow Skin Fibroblasts Cell Line Hematopoietic Stem Cells HL-60 Cells Tumor Cells, Cultured Stromal Cells Brain Bone Marrow Cells

Organisms6

Rats, Sprague-Dawley Mice, Inbred BALB C Mice, SCID Dogs Mice, Nude Mice, Inbred C57BL

Diseases44

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Mastocytosis, Systemic Dermatofibrosarcoma Fibromatosis, Aggressive Nausea Lichenoid Eruptions Vomiting Leukemia, Myeloid, Accelerated Phase Recurrence Neutropenia Thrombocytopenia Primary Myelofibrosis Neoplasm, Residual Disease Progression Histiocytoma, Malignant Fibrous Neoplasms Scleroderma, Systemic Anorexia Graves Ophthalmopathy Fibrosis Leukemia Disease Models, Animal Spinal Cord Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm Metastasis Chromosome Aberrations Bone Neoplasms Pulmonary Fibrosis Nerve Sheath Neoplasms Myeloproliferative Disorders Peripheral Nervous System Diseases Peritoneal Neoplasms Brain Neoplasms Skin Neoplasms Carcinoma, Small Cell Neoplasm Recurrence, Local

Chemicals and Drugs103

Benzamides Piperazines Pyrimidines Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Dosage Forms Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor beta Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Mesylates Pergolide Fenoldopam Enzyme Inhibitors Pefloxacin Benzoxazines Delavirdine Receptors, Platelet-Derived Growth Factor Tubulin Modulators Naphthalenes Quinolizines Pralidoxime Compounds Nelfinavir Gabexate Proto-Oncogene Proteins c-sis Pyrroles Morpholines Antimitotic Agents Ergolines Cannabinoid Receptor Agonists Bromocriptine Dihydroergotoxine Cannabinoids Harringtonines Indoles Rifabutin Interferon-alpha mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Doxazosin Tablets RNA, Messenger Dexamethasone Drug Combinations Piperidines Receptors, Glucocorticoid Thiazoles Hydroxyurea Lipid Peroxides STAT5 Transcription Factor Receptors, Cannabinoid Phentolamine Platelet-Derived Growth Factor Antiemetics Free Radical Scavengers Adrenergic alpha-Antagonists Camptothecin Topotecan Stem Cell Factor Antineoplastic Agents, Phytogenic Receptor, Cannabinoid, CB1 Pyrazoles Cannabinoid Receptor Antagonists Naphthyridines Oncogene Proteins, Fusion Milk Proteins Dronabinol Delayed-Action Preparations Affinity Labels Antigens, CD34 Cyclohexanols Neoplasm Proteins Triamcinolone Acetonide HIV Protease Inhibitors Iron Chelating Agents Lactams, Macrocyclic Cytarabine Bleomycin P-Glycoprotein DNA-Binding Proteins Pyridines Deoxycytidine ATP-Binding Cassette Transporters Capsules Benzoquinones src-Family Kinases Imidazoles Proto-Oncogene Proteins c-bcl-2 Neuroprotective Agents Receptors, Steroid Tumor Markers, Biological Cannabinoid Receptor Modulators Anti-HIV Agents Receptors, Granulocyte Colony-Stimulating Factor Proto-Oncogene Proteins c-akt Drosophila Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment50

Dosage Forms Cytogenetic Analysis Treatment Outcome Administration, Oral Drug Administration Schedule Remission Induction Drug Approval Disease-Free Survival Drug Dosage Calculations Area Under Curve Double-Blind Method Survival Analysis Antineoplastic Combined Chemotherapy Protocols Chromatography, High Pressure Liquid Treatment Failure Drug Therapy, Combination In Situ Hybridization, Fluorescence Prognosis Follow-Up Studies Salvage Therapy Infusions, Intravenous Reverse Transcriptase Polymerase Chain Reaction Survival Rate Maximum Tolerated Dose Clinical Trials as Topic Retreatment Immunohistochemistry Blood Cell Count Combined Modality Therapy Drug Stability Inhibitory Concentration 50 Blotting, Western Disease Models, Animal Neoadjuvant Therapy Prospective Studies Transplantation, Homologous Delayed-Action Preparations Retrospective Studies DNA Mutational Analysis Positron-Emission Tomography Injections, Intravenous Karyotyping Polymerase Chain Reaction Hematopoietic Stem Cell Transplantation Drug Screening Assays, Antitumor Drug Evaluation, Preclinical Gene Expression Profiling Oligonucleotide Array Sequence Analysis Xenograft Model Antitumor Assays Reproducibility of Results

Phenomena and Processes38

Gene Dosage Dosage Compensation, Genetic Dose-Response Relationship, Drug Drug Resistance, Neoplasm Genes, abl Philadelphia Chromosome Time Factors Apoptosis Mutation X Chromosome Drug Synergism Area Under Curve Cell Proliferation Phosphorylation Chromosomes, Human, Pair 9 Drug Interactions Maximum Tolerated Dose Cell Survival Signal Transduction Blood Cell Count Genes, X-Linked Gene Expression Regulation, Leukemic Sex Chromosomes Inhibitory Concentration 50 Cell Division Half-Life X Chromosome Inactivation Chromosome Aberrations G0 Phase Tissue Distribution Gene Expression Gene Expression Regulation, Neoplastic Kinetics Down-Regulation Gene Expression Regulation Molecular Structure Phenotype Transcription, Genetic

Disciplines and Occupations3

Cytogenetics Immunohistochemistry Chemistry, Pharmaceutical

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science1

Health Care13

Treatment Outcome Disease-Free Survival United States Food and Drug Administration Area Under Curve Double-Blind Method Survival Analysis Treatment Failure Follow-Up Studies Survival Rate Clinical Trials as Topic Prospective Studies Retrospective Studies Reproducibility of Results

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Benzamides Piperazines Pyrimidines Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Gene Dosage Proto-Oncogene Proteins c-kit Dosage Compensation, Genetic Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Dosage Forms Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor beta Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Dose-Response Relationship, Drug Cytogenetic Analysis Drug Resistance, Neoplasm Genes, abl Treatment Outcome Protein-Tyrosine Kinases Ergoloid Mesylates Gastrointestinal Neoplasms Deferoxamine Proto-Oncogene Proteins c-abl K562 Cells Administration, Oral Mesylates Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Pergolide Philadelphia Chromosome Drug Administration Schedule Fenoldopam Remission Induction Enzyme Inhibitors Drug Approval Pefloxacin Benzoxazines Delavirdine Mastocytosis, Systemic Dermatofibrosarcoma Receptors, Platelet-Derived Growth Factor Tubulin Modulators Time Factors Naphthalenes Quinolizines Pralidoxime Compounds Cell Line, Tumor Nelfinavir Gabexate Fibromatosis, Aggressive Proto-Oncogene Proteins c-sis Pyrroles Morpholines Disease-Free Survival Nausea Antimitotic Agents Ergolines Apoptosis Mutation X Chromosome Cannabinoid Receptor Agonists Bromocriptine Dihydroergotoxine Drug Synergism Cannabinoids United States Food and Drug Administration Lichenoid Eruptions Drug Dosage Calculations Area Under Curve Cell Proliferation Harringtonines Indoles Phosphorylation Rifabutin Interferon-alpha mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Double-Blind Method Survival Analysis Vomiting Antineoplastic Combined Chemotherapy Protocols Chromatography, High Pressure Liquid Leukemia, Myeloid, Accelerated Phase Recurrence Neutropenia Doxazosin Treatment Failure Tablets Drug Therapy, Combination In Situ Hybridization, Fluorescence RNA, Messenger Thrombocytopenia Prognosis

No FAQ available that match "dosage mesylate"